14 sources checked · Left, Center, and Right included · 52m ago
Different Spin
FDA approves first m RNA flu vaccine for adults 50+
Fast Company and The Gateway Pundit describe the same event in different terms.
1 Left11 Center2 Right
Same story. Different framing.Left, center, and right outlets are covering the same event. Here’s how each side worded it.
DIFFERENT SPIN
HOW EACH SIDE WORDED IT
Left-leaningCenter-leftThis new kind of flu shot by Moderna has just been approved by the FDAFast CompanyMostly Factual
vs
Right-leaningCenter-rightPa. experts welcome FDA approval of Moderna’s m RNA flu vaccinePittsburgh Tribune ReviewMostly Factual
Center baseline · WBIR10 (Tegna, Knoxville)HighFDA approves first m RNA flu vaccine for adults 50+
As of August 6, 2026 at 4:17 PM, this is how Optics News reads the wording differences in this story.
What happenedThe shot, named m Flusiva, is intended for adults age 50 or older.
The headline splitThe left frames it as "This new kind of flu shot by Moderna has just been approved by the FDA". The right frames it as "Pa. experts welcome FDA approval of Moderna’s m RNA flu vaccine".
Match confidenceHigh confidence. 14 sources checked, Left/Center/Right all represented. Best read as a clear framing signal — not a fact-check.
Same-event confidenceHigh
14 sources across Left, Center, and Right all describe the same event.
Framing confidenceStrong
81/99 — headlines create a clearly different first impression.
WHAT EACH SIDE EMPHASIZED
Left / center-leftThis new kind of flu shot by Moderna has just been approved by the FDA
Fast Company · Center-left · News report
CenterFDA approves first m RNA flu vaccine for adults 50+
WBIR10 (Tegna, Knoxville) · Center · News report
Right / center-rightPa. experts welcome FDA approval of Moderna’s m RNA flu vaccine
Pa. experts welcome FDA approval of Moderna’s m RNA flu vaccine
Despite an uptick in vaccine skepticism among Americans, Pennsylvania doctors lauded the Food and Drug Administration’s approval Wednesday of the first m RNA flu vaccine.
The Food and Drug Administration on Wednesday approved the first m RNA flu vaccine, enabling use of a technology that will make it easier to rapidly target a widely prevalent or particularl...
FDA Reverses Course, Approves Moderna’s Experimental m RNA Flu Vaccine Months After Initial Rejection
The Food and Drug Administration (FDA) has approved Moderna’s experimental m RNA influenza vaccine, reversing an earlier decision that blocked the application over concerns about the compan...
This new kind of flu shot by Moderna has just been approved by the FDA
The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same m RNA technology that was key to ending the COVID-19 pandemic, said th...
FDA approves Moderna’s m RNA-based vaccine for the flu
The shot, named m Flusiva, is intended for adults age 50 or older. Moderna said late Wednesday that it expects some of its new version to be available soon at select retailers.